David Jones

David Jones

Director/Board Member at NUFARM LIMITED

Net worth: 294 232 $ as of 30/03/2024

Process Industries
Health Technology
Consumer Services

Profile

David Jones is currently the Chairman at Enko Chem, Inc., Zyzzle Ltd., and an Independent Non-Executive Director at Nufarm Ltd.
and Nufarm Australia Ltd.
He previously held positions as Chairman at Plant Impact Ltd.
and Non-Executive Chairman at Arysta LifeScience Corp.
He also served as Chairman at Astrazeneca China Ltd.
and Syngenta Asia Pacific Ltd.
and as a Director at Zeneca Agrochemicals.
Additionally, he was the Business Manager-Europe at AstraZeneca PLC from 1989 to 1992 and the Head-Business Development at Syngenta International AG from 2000 to 2007.
Dr. Jones holds an undergraduate and doctorate degree from The University of Stirling.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/09/2023 82,000 ( 0.02% ) 294 232 $ 30/03/2024

David Jones active positions

CompaniesPositionStart
NUFARM LIMITED Director/Board Member 22/06/2021
Chairman 30/06/2021
Chairman 31/12/2019
Director/Board Member 22/06/2021
All active positions of David Jones

Former positions of David Jones

CompaniesPositionEnd
Corporate Officer/Principal 31/12/2006
ASTRAZENECA PLC Corporate Officer/Principal 31/12/1991
Syngenta Asia Pacific Ltd. Chairman -
Astrazeneca China Ltd. Chairman -
PLANT IMPACT PLC Chairman -
See the detail of David Jones's experience

Training of David Jones

The University of Stirling Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Jones's experience

Connections

40

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ASTRAZENECA PLC

Health Technology

NUFARM LIMITED

Process Industries

Private companies10

Process Industries

Zeneca Agrochemicals

Process Industries

Process Industries

Process Industries

Process Industries

Astrazeneca China Ltd.

Health Technology

Commercial Services

Syngenta Asia Pacific Ltd.

See company connections